| 臺大學術典藏 |
2021-08-15T00:07:45Z |
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients
|
Cheng, Huei Ru; HUNG-CHIH YANG; Lin, Su Ru; Yang, Ta Yu; Lin, You Yu; TUNG-HUNG SU; Tseng, Tai Chung; CHUN-JEN LIU; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-07-03T02:10:37Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin, Su Ru; Yang, Ta Yu; Peng, Cheng Yuan; Lin, You Yu; Dai, Chia Yen; HURNG-YI WANG; TUNG-HUNG SU; Tseng, Tai Chung; Liu, I. Jung; Cheng, Huei Ru; Shen, Yueh Chi; Wu, Fang Yi; CHUN-JEN LIU; DING-SHINN CHEN; Chen, Pei-Jer; HUNG-CHIH YANG; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-04-29T06:39:08Z |
Improved second harmonic generation and two-photon excitation fluorescence microscopy-based quantitative assessments of liver fibrosis through auto-correction and optimal sampling
|
Hsiao, Chih Yang; Teng, Xiao; TUNG-HUNG SU; PO-HUANG LEE; Kao, Jia-Horng; KAI-WEN HUANG |
| 臺大學術典藏 |
2021-04-21T23:30:27Z |
Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
|
Lin, Su Ru; Yang, Ta Yu; Peng, Cheng Yuan; Lin, You Yu; Dai, Chia Yen; HURNG-YI WANG; TUNG-HUNG SU; Tseng, Tai Chung; Liu, I. Jung; Cheng, Huei Ru; Shen, Yueh Chi; Wu, Fang Yi; CHUN-JEN LIU; DING-SHINN CHEN; Chen, Pei-Jer; HUNG-CHIH YANG; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-03-09T02:29:08Z |
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis
|
Yang, Hwai-I;Tseng, Tai-Chung;Liu, Jessica;Lee, Mei-Hsuan;Liu, Chun-Jen;Tung-Hung Su;Batrla-Utermann, Richard;Chan, Henry Lik-Yuen;Kao, Jia-Horng;Chen, Chien-Jen; Yang, Hwai-I; Tseng, Tai-Chung; Liu, Jessica; Lee, Mei-Hsuan; Liu, Chun-Jen; TUNG-HUNG SU; Batrla-Utermann, Richard; Chan, Henry Lik-Yuen; Kao, Jia-Horng; Chen, Chien-Jen |
| 臺大學術典藏 |
2021-03-09T01:47:48Z |
Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection
|
TUNG-HUNG SU; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:48Z |
Leakage of air bubbles in subcutaneous emphysema
|
TUNG-HUNG SU; Ku S.-C. |
| 臺大學術典藏 |
2021-03-09T01:47:48Z |
APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers [5]
|
TUNG-HUNG SU; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-03-09T01:47:47Z |
The passage of a colonic cast
|
TUNG-HUNG SU; Liou J.-M.; Wang H.-P. |
| 臺大學術典藏 |
2021-03-09T01:47:47Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
TUNG-HUNG SU; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:47Z |
Unusual dyspnoea in a patient with liver cirrhosis
|
TUNG-HUNG SU; Liu W.-L.; Yu C.-J.; Huang G.-T. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters
|
Tseng T.; Liu C.; TUNG-HUNG SU; Wang C.; Chen C.; Chen P.; Chen D.; Kao J. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; TUNG-HUNG SU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
The clinical significance of occult hepatitis B transfusion in Taiwan - a look-back study
|
TUNG-HUNG SU; Chen P.-J.; Chen T.-C.; Cheng H.-R.; Li L.; Lin K.-S.; Kao J.-H.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:45Z |
Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters
|
Tseng T.-C.; Liu C.-J.; Chen C.-L.; Wang C.-C.; TUNG-HUNG SU; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:45Z |
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:45Z |
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:45Z |
Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission
|
Lin C.-L.; Tseng T.-C.; TUNG-HUNG SU; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:44Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; TUNG-HUNG SU; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:44Z |
Emerging hepatitis B virus infection in vaccinated populations: A rising concern?
|
TUNG-HUNG SU; Chen P.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:44Z |
Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation
|
Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:43Z |
Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
|
Cheng H.-R.; Liu C.-J.; Tseng T.-C.; TUNG-HUNG SU; Yang H.-I.; Chen C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:43Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
|
Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:43Z |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-03-09T01:47:43Z |
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
|
Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Hsu C.-S.; Lin H.H.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:42Z |
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers
|
Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:42Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
TUNG-HUNG SU; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-03-09T01:47:42Z |
Milder clinical manifestation of scrub typhus in Kinmen, Taiwan
|
TUNG-HUNG SU; Liu C.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:41Z |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:41Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:41Z |
Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
|
TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:40Z |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin
|
Chen M.-Y.; Liu C.-H.; Chen T.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:40Z |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:40Z |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:39Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection
|
Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:39Z |
Molecular mechanism and treatment of viral hepatitis-related liver fibrosis
|
TUNG-HUNG SU; Kao J.-H.; Liu C.-J. |
| 臺大學術典藏 |
2021-03-09T01:47:38Z |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Lin H.H.; Wang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:38Z |
Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir
|
Chen G.-Y.; TUNG-HUNG SU; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:38Z |
Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B
|
Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU; Liu C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:38Z |
Improving clinical outcomes of chronic hepatitis B virus infection
|
TUNG-HUNG SU; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:37Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
TUNG-HUNG SU; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2021-03-09T01:47:37Z |
Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:37Z |
Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection
|
Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:37Z |
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy
|
Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; TUNG-HUNG SU; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:36Z |
Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus
|
Chen H.-L.; Lee C.-N.; Chang C.-H.; Ni Y.-H.; Shyu M.-K.; Chen S.-M.; Hu J.-J.; Lin H.H.; Zhao L.-L.; Mu S.-C.; Lai M.-W.; Lee C.-L.; Lin H.-M.; Tsai M.-S.; Hsu J.-J.; Chen D.-S.; Chan K.A.; Chang M.-H.; Su Y.-N.; Shih J.-C.; Chao K.-H.; Wu J.-F.; Hsu H.-Y.; Liu C.-J.; TUNG-HUNG SU; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Lin L.-H.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Peng F.-S.; Lin Y.-C.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT Study) |
| 臺大學術典藏 |
2021-03-09T01:47:36Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-03-09T01:47:35Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:35Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
